As of June 30, 2026, Modular Medical, Inc. carries a market capitalization of 24.36M, placing it among publicly traded companies globally. Its enterprise value stands at 20.72M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 24.36M |
| Enterprise Value | 20.72M |
Modular Medical, Inc.'s next confirmed earnings release is scheduled for December 2, 2026.
| Earnings Date | 12/2/2026 |
As of June 30, 2026, Modular Medical, Inc. has 5.41M shares outstanding.
| Shares Outstanding | 5.41M |
These figures are as of June 30, 2026.
| PB Ratio | 2.26 |
| P/TBV Ratio | 2.26 |
| P/FCF Ratio | -0.57 |
| P/OCF Ratio | -0.65 |
As of June 30, 2026, Modular Medical, Inc. maintains a current ratio of 3.25, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 3.25 |
| Quick Ratio | 2.79 |
| Debt / Equity | 2.58 |
| Debt / EBITDA | -0.01 |
Over the twelve months ended June 30, 2026, Modular Medical, Inc. posted a negative return on equity (ROE) of -247.94, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -212.13, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 52.50, a quick read on workforce productivity versus industry peers.
| Return on Equity (ROE) | -247.94 |
| Return on Assets (ROA) | -212.13 |
| Employee Count | 52.50 |
Over the twelve months ended June 30, 2026, Modular Medical, Inc. recorded 2,000.00 in income tax expense. The company reported a pretax loss of -28.02M and -28.03M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.
| Income Tax | 2,000.00 |
As of the close on November 16, 2026, Modular Medical, Inc.'s stock has declined approximately 88.06% over the past 52 weeks. The 50-day moving average sits at 2.10, while the 200-day moving average is 5.32.
| 52-Week Price Change | -88.06% |
| 50-Day Moving Average | 2.10 |
| 200-Day Moving Average | 5.32 |
Over the twelve months ended June 30, 2026, Modular Medical, Inc. generated - - in revenue and converted that into -28.03M in net income, yielding earnings per share of -7.92. EBITDA reached -25.53M, while operating income came in at -27.29M.
| Operating Income | -27.29M |
| Pretax Income | -28.02M |
| Net Income | -28.03M |
| EBITDA | -25.53M |
| EBIT | -27.29M |
| Earnings Per Share (EPS) | -7.92 |
As of June 30, 2026, Modular Medical, Inc. holds 3.92M in cash and equivalents against 278,000.00 in total debt, resulting in a net debt position of -3.92M. Total book value stands at 10.76M, with working capital of 3.36M providing operational flexibility.
| Cash & Cash Equivalents | 3.92M |
| Total Debt | 278,000.00 |
| Net Debt | -3.92M |
| Equity (Book Value) | 10.76M |
| Book Value Per Share | 1.99 |
| Working Capital | 3.36M |
Modular Medical, Inc. produced -24.35M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -3.69M in capital expenditures, free cash flow totaled -28.04M - equivalent to -7.92 per share.
| Operating Cash Flow | -24.35M |
| Capital Expenditures | -3.69M |
| Free Cash Flow | -28.04M |
| FCF Per Share | -7.92 |
These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -175.97: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -100.32, meaning Modular Medical, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -100.32 |
| FCF Yield | -175.97 |
Modular Medical, Inc.'s most recent stock split took place on March 31, 2026 with a 30:1 split ratio.
| Last Split Date | 3/31/2026 |
| Split Ratio | 30:1 |
As of June 30, 2026, Modular Medical, Inc. has an Altman Z-Score of -10.86, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -10.86 |